Drugs
EXTON, PA: EXTON, PA -- (Marketwired) -- 02/20/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2015 dividend of $0.1 ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 02/17/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the Company will release its financial results for the fourth quarter and year-end 2014 on Tue ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/17/15 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company w ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/13/15 -- M Pharmaceutical Inc., ( the "Company") (CSE: MQ) wishes to outline its anticipated 2015 milestones in conducting the advancemen ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/11/15 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the fourth quarter and full year ended December 31, ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/11/15 --Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/10/15 -- Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, orally available small molecule therapeutics for the treatment o ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwired) -- 02/10/15 -- Cytovance® Biologics, Inc., a leading full service contract manufacturer of mammalian and microbial biologics, announces that April Stanley, Manager ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/09/15 -- Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK: SPRWF)(CSE: SL) is pleased to announce it has completed its operational transition ...
NEW YORK, NY: Review Underscores Therapeutic Potential of ROCK2 Inhibition in Autoimmune Disease ...
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA: LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/09/15 -- GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a second ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/06/15 -- Theravance, Inc. (NASDAQ: THRX) today announced that on March 19, 2015, the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Ad ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/05/15 -- Global Blood Therapeutics (GBT), a clinical stage biopharmaceutical company developing novel small molecule therapeutics for the treatment of s ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/05/15 -- (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 2015 BIO CEO & Investor Conference, February 9-10, in New York, NY.Yako ...
CLARKSVILLE, MD: CLARKSVILLE, MD -- (Marketwired) -- 02/05/15 -- The US Patent Office issued an allowance to Neuronascent, Inc. expanding patent protection of their new therapeutic candidate, NNI-362, beyond composit ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/04/15 -- Merus Labs International Inc. (TSX: MSL)(NASDAQ: MSLI) ("Merus" or "the Company") today announced the appointment of Geoff Morrow ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 01/29/15 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquirin ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 01/29/15 -- (NASDAQ: CBLI) today announced updates on oncology clinical development of entolimod (previously known as CBLB502).Entolimod is a toll-like receptor 5 (TLR ...
PARIS, FRANCE: PARIS, FRANCE -- (Marketwired) -- 01/29/15 --PARIS, FRANCE, January 29th2015: OSE Pharma, a biotechnology company developing T-cell specific immunotherapy, and Simbec-Orion, a leading global clinical ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 01/29/15 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") is pleased to report that up to 6 new b ...
